Fusion to an albumin-binding domain with a high affinity for albumin extends the circulatory half-life and enhances the in vivo antitumor effects of human TRAIL.
| Image |  |
|---|---|
| Description | scientific article published on 04 March 2016 |
| Author/s |
author: Huawei Cai |
| Publication date | March 4, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |